ecallantide: Clinical Trials

1 trial of ecallantide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow ecallantide: new trials by email Literature Review of ecallantide trials Research Report on ecallantide

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
FOV2302 (Ecallantide) - Macular Edema, Central Retinal Vein Occlusion
Phase 1TerminatedFovea Pharmaceuticals SA112009-09-012012-01-10

Conditions studied

Macular Edema (1)  ·  Retinal Vein Occlusion (1)

Sponsors

Fovea Pharmaceuticals SA (1)

Countries

France (1)

Top investigators

Alain Gaudric, MD (1)